Santa Cruz Recalls Subpotent UltraCruz Hand Sanitizing Gel
Santa Cruz Biotechnology is recalling 14,238 bottles of UltraCruz Hand Sanitizing Gel because the product is subpotent.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which indicates a reasonable probability of temporary or medically reversible health consequences. The hazard is a subpotent drug, which is a quality issue rather than a contamination or acute injury risk.
Plain-English summary
Santa Cruz Biotechnology, Inc. is voluntarily recalling 14,238 bottles of UltraCruz Hand Sanitizing Gel Antimicrobial (70% Isopropyl Alcohol). The product is packaged in 3 Fluid Oz./89 mL bottles and was distributed nationwide in the United States.
The recall was initiated because the product is a subpotent drug, meaning it does not contain the full amount of the active ingredient required by its label. The specific lot number is BF12530, with an expiration date of 05/11/2022.
Consumers who have this product should stop using it and contact the manufacturer for further instructions. The recall was initiated on August 7, 2020, and was terminated on June 14, 2021.
The recalled product
- Product
- UltraCruz Hand Sanitizing Gel Antimicrobial (70% Isopropyl Alcohol), packaged in 3 Fluid Oz./89 mL bottes, Manufactured By Santa Cruz Biotechnology, Inc. 10410 Finnell St. Dallas, TX 75220
- Manufacturer
- Santa Cruz Biotechnology, Inc
- Category
- Drug — Hand Sanitizer
- Hazard
- Affected units
- 14,238
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: BF12530
- Exp 05/11/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · subpotent drug
See all →- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02